InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Kuriakose Emil. Officer active across 2 companies, notably Calithera Biosciences, Inc.. In total, 11 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €86k. History available since 5 November 2021. The latest transaction was disclosed on 1 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Kuriakose Emil is a declarant linked to Terns Pharmaceuticals, Inc. and Calithera Biosciences, Inc., with the listed role of Chief Medical Officer and CHIEF MEDICAL OFFICER. Across 11 filings, the 11 sampled filings run from 2021-11-09 to 2026-04-02 and show only sales, with sum_sell_eur of 85937 and sum_buy_eur of 0, and the transaction nature listed as Cession.